STAT3 and neoplasm: To understand whether anti-tumor effect of paclitaxel can also be enhanced by other JAK/STAT3 inhibitors, AZD1480, another JAK/STAT3 inhibitor, was combined with paclitaxel in MDAH2774 cells.